Dana-Farber researchers say discovery may help identify kidney cancer and melanoma patients that will benefit from checkpoint inhibitor treatment

The algorithm can accurately predict the interactions between a protein and a drug molecule based on a handful of reference experiments or simulations

Labs at Duke and other academic centers collaborate to identify alternatives to antibiotics

Combines EMR and NLP data to deliver the industry’s most comprehensive data set for cohort analysis and site selection

Next generation protein engineering technology for improved drug candidate decision making

According to research firm Market Research Future (Pune, India), the global biomarker test market will reach $16 billion by 2022

Tuberculosis could be fought more effectively with future drugs—thanks to new research into an old antibiotic by University of Warwick and Francis Crick Institute

Research led by scientists at the University of Birmingham shows more precisely how G protein-coupled receptors, which are the key target of a large number of drugs, work

Articles in the December 2017 special issue of SLAS Discovery present a snapshot of innovation in the MALDI application space as it stands today

Computer modeling and simulation has become a vital part of the drug development process